ASTAL LABORATORIES LIMITED
Astal Laboratories Limited has intimated BSE Limited about an upcoming board meeting scheduled for Friday, 13th November, 2026. The meeting will be held at the company's corporate office at House No 4-50 1 Sy No 134 132 Block B 8th Floor Flat No 801, The Platina Kondapur Road, Gachibowli, K.V.Rangareddy, Seri Lingampally, Telangana, India, 500032.
The primary agenda items for the board meeting include:
- Consideration and approval of unaudited standalone financial results for the quarter and half year ended 30th September, 2026
- Consideration and approval of unaudited consolidated financial results for the quarter and half year ended 30th September, 2026
- Review of the Limited Review Report from the auditors
- Any other matter with the permission of the chair
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's Code of Conduct for Prevention of Insider Trading, the trading window for designated persons and their immediate relatives has been closed since October 1, 2026. The trading window will remain closed until forty-eight hours after the conclusion of the board meeting on November 13, 2026.
The disclosure is made under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has requested BSE to take this information on record for dissemination through their website.